Led · Seed · Jan 2026

Founded in 2022 and headquartered in Amsterdam, Root Sustainability provides a software platform that centralizes a company’s environmental data to automatically generate product-level and organization-wide life-cycle assessments (LCAs). By aggregating previously scattered operational data across the value chain, the system delivers actionable insights that help clients optimize sustainability performance and decarbonize operations. The startup counts retailers such as HEMA, O’Neill, and Holland & Barrett among its early customers. Root Sustainability’s product roadmap includes enhancing its artificial-intelligence capabilities to streamline data optimization and broaden decarbonization recommendations. The recently secured seed capital will also support the company’s planned expansion across Europe. Although detailed revenue or user metrics were not disclosed, the new funding represents its first institutional round and solidifies its financial foundation for growth.

Led · Seed · Jan 2026

Founded in 2019 at the High Tech Campus in Eindhoven, ShanX Medtech (SXM) is developing an in-vitro diagnostic (IVD) platform that performs direct-from-sample antimicrobial susceptibility testing (AST). The system uses the company’s proprietary FLORA™ chemistry to monitor pathogen metabolism in real time, enabling clinicians to obtain actionable results in about sixty minutes with minimal user involvement. ShanX’s initial go-to-market focus is a women’s health application targeting urinary tract infections, though the underlying technology is positioned for broader clinical indications. The startup’s mission is to give every clinician rapid, evidence-based guidance to combat antimicrobial resistance. To date, ShanX has secured €24 million in financing, including a new €15 million seed round and an €8.85 million European Commission contract. The fresh capital will fund final product development, clinical validation, regulatory approval and commercial launch preparations. No revenue or user metrics have been disclosed.

Led · Equity · Nov 2025

Founded in 2019 and based in Birmingham, Rem3dy Health is the parent company of the personalised nutrition brand Nourished, combining AI-driven personalised nutrition with advanced manufacturing techniques. The company integrates data science, 3D printing and automation to produce tailored health solutions at scale. Its positioning is more consumer-wellness oriented within the broader health technology landscape. Rem3dy has stated plans to expand into key international markets including the US, MENA region and India, and to enter personalised health solutions for pets. The recent €16 million strategic fundraising is intended to support that global scaling and market entry. The company has attracted strategic investors from both consumer and healthcare sectors, reflecting a move to partner with established global players.

Participated · Equity · Jul 2025

Novenda Technologies develops a full-stack multi-material 3D printing platform that produces single-piece dental products combining hard and soft materials, using water-soluble supports and proprietary software and materials. Its LD100 printer prints up to 15 nightguards and 8 dentures per hour and works exclusively with Novenda’s own materials, creating recurring consumables revenue. The company has eliminated mechanical rollers with smart print modes and uses a colour-management algorithm to achieve wide colour ranges while preserving mechanical properties. Novenda was founded in 2019 and built a team of fifteen experts across physics, chemistry, material science, and software engineering, with multiple patents filed. Early industry feedback praised surface finish and aesthetics, and the company achieved its first multi-material print in 2021 and proof of concept for nightguards and dentures in 2023. Novenda plans to expand into additional dental applications and scale deployments in mid-size and large dental labs across Europe and the US.

Participated · Equity · Dec 2024

Founded in 2014 by Daniela Sordi and Rutger van Raalten, CarbonX is engineering a novel, locally produced anode material designed to replace graphite in lithium-ion batteries. Its patented 3D porous network improves electron and lithium transport, embeds nano-sized silicon, and ultimately raises energy density for applications such as electric vehicles. By tapping existing carbon black plants, the firm can manufacture at graphite-competitive costs while sharply reducing energy use and emissions, helping Europe and the U.S. build independent battery supply chains. Strategically based near Delft University of Technology in the Netherlands, CarbonX also supports battery cell validation for customers. The company positions its process as a solution to global graphite shortages and European dependence on Asian suppliers. Although no revenue or customer numbers were disclosed, the technology has attracted attention from automotive battery stakeholders. The recent EIC award validates the technology and provides capital to accelerate commercialization and market expansion.